Giant Cell Arteritis and Anakinra Trial (GiAnT)
Randomized, Controlled, Double-blind Study of Anakinra Against Placebo in Addition to Steroids in Giant Cell Arteritis
Sponsor: Amiens University Hospital
This PHASE3 trial investigates Giant Cell Arteritis and is currently ongoing. Amiens University Hospital leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Apr 2022 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jan 2021 — Apr 2022 [monthly]
Recruiting PHASE3
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Jun 2018 — Mar 2020 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Amiens University Hospital
- Central Hospital Saint Quentin
- Hôpital Claude-Huriez
- University Hospital, Caen
- University Hospital, Limoges
- University Hospital, Rouen
- Valenciennes Hospital, Valenciennes, FRANCE
For direct contact, visit the study record on ClinicalTrials.gov .